Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Rhabdomyosarcoma × Imatinib Mesylate × Clear all

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 33 Leukemia 23 Precursor Cell Lymphoblastic Leukemia-Lymphoma 15 Leukemia, Myeloid, Chronic-Phase 12 Gastrointestinal Stromal Tumors 12 Philadelphia Chromosome 5 Leukemia, Myeloid 5 Brain Neoplasms 5 Carcinoma, Non-Small-Cell Lung 4 Blast Crisis 4 Recurrence 3 Prostatic Neoplasms 3 Melanoma 3 Lung Neoplasms 3 Leukemia, Myeloid, Acute 3 Hematologic Diseases 3 Glioblastoma 3 Bone Marrow Diseases 3 Stomach Neoplasms 2 Sarcoma 2 Ovarian Neoplasms 2 Neoplasms by Histologic Type 2 Neoplasm Metastasis 2 Myeloproliferative Disorders 2 Meningioma 2 Leukemia, Myeloid, Accelerated Phase 2 Gliosarcoma 2 Glioma 2 Digestive System Neoplasms 2 Carcinoma, Renal Cell 2

Interventions

Irinotecan 7 Cyclophosphamide 7 Vincristine 6 Dactinomycin 5 temsirolimus 4 cixutumumab 4 Sirolimus 4 Radiotherapy 4 Magnetic Resonance Spectroscopy 4 Etoposide 4 X-Rays 3 Radiation 3 Phantoms, Imaging 3 Doxorubicin 3 thymoglobulin 2 fludarabine phosphate 2 eribulin 2 Vinorelbine 2 Temozolomide 2 Tacrolimus 2 Stem Cell Transplantation 2 Specimen Handling 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy, Image-Guided 2 Peripheral Blood Stem Cell Transplantation 2 Nuclear Medicine Department, Hospital 2 Nivolumab 2 Melphalan 2 Ifosfamide 2 Gemcitabine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡